| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 23,942,345 | 26,205,837 | 16,209,000 | | Cost of Revenue | 15,774,543 | 17,797,051 | 10,837,000 | | | Gross Profit | 8,167,802 | 8,408,786 | 5,372,000 | | | Operating Expenses | | Research Development | 3,886,543 | 4,350,947 | 1,935,000 | | Selling General and Administrative | 4,360,202 | 4,719,172 | 2,521,000 | | Non Recurring | 7,396,696 | 5,597,020 | 1,099,000 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,475,639) | (6,258,352) | (183,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 768,287 | 1,135,606 | 69,000 | | Earnings Before Interest And Taxes | (6,572,021) | (4,960,727) | (114,000) | | Interest Expense | 551,193 | 593,579 | 318,000 | | Income Before Tax | (7,123,214) | (5,554,306) | (432,000) | | Income Tax Expense | 215,684 | 465,436 | (49,000) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,338,898) | (6,019,742) | (383,000) | | | Non-recurring Events | | Discontinued Operations | 46,520 | 898,469 | 210,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,292,378) | (5,121,273) | (173,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,292,378) | ($5,121,273) | ($173,000) |
|
0.03% Nasdaq 0.00%
Income Statement
